NITRIC oxide (NO) in¯uences electrophysiological and morphological parameters of the mammalian cochlea. Recently, the isoform of the NO-producing enzyme neuronal NO synthase (nNOS) has been demonstrated in spiral ganglion cells and olivocochlear neurons. The cochlea is also innervated by ®bers stemming from the trigeminal ganglion (TG) and superior cervical ganglion (SCG). Whether these ganglion cells contain nNOS is not known yet. We therefore identi®ed TG and SCG cells upon injection of Fluoro-Gold (FG) into the cochlea and retrograde neuronal transport of FG in rat and guinea pig. These ganglion cells were investigated for neuronal NOS immunohistochemically. Perikarya labeled by FG were found in the ipsilateral TG and SCG. In both species investigated, a considerable number of FG-labeled TG cells were also nNOS-immunoreactive whereas SCG cells were not. These data, demonstrating the existence of nNOS-containing TG cells that project to the cochlea, provide evidence that these neurons are further sources of nitric oxide in the cochlea. NeuroReport 10:2641±2645 # 1999 Lippincott Williams & Wilkins.
Introduction
Nitric oxide (NO) is involved in the regulation of various physiological and pathological mechanisms in the mammalian body. In the auditory system, it has been shown to in¯uence cochlear blood¯ow [1] , endocochlear potentials [2] and, in high doses, to induce the degeneration of afferent connections of the inner hair cells [3] . NO is formed by three known isoforms of the enzyme nitric oxide synthase [4] . The neuronal isoform (nNOS) has been demonstrated in spiral ganglion cells and neuronal structures in the organ of Corti [5±8] . Furthermore, neurons of the superior olivary complex which project to the cochlea via the olivocochlear bundle have been shown to contain nNOS immunoreactivity in rats and guinea pigs [8, 9] . These cochlear and brainstem structures have therefore been supposed to be the main sources of cochlear NO. However, the mammalian cochlea is also innervated by ®bers steming from the sympathetic superior cervical ganglion (SCG) [10] and the sensory trigeminal ganglion (TG) [11] .
This innervation pattern and the presence of nNOS immunoreactivity in TG neurons [12, 13] initiated the present study. It was conducted to investigate whether TG or SCG cells that were identi®ed to project to the cochlea exhibit nNOSimmunoreactivity.
Materials and Methods
The procedures concerning animals in this study complied with German legislation for the protection of animals and were approved by the countrygovernment of®ce (Bezirksregierung RheinhessenPfalz, Az 177-07/961-30). Five adult male Sprague± Dawley rats (200±220 g) and ®ve adult male guinea pigs (450±500 g) were anesthetized with tribromoethanol (0.3 g/kg) and received pressure injections of 500 nl of a 5% Fluoro-Gold solution (FG; Fluorochrome, Englewood, Colorado, USA; dissolved in distilled water) into the left scala tympani. The surgical approach is described elsewhere [14, 15] . Five days later the animals were reanesthetized and perfused transcardially with a 100 mM phosphatebuffered, 0.9% saline solution (PBS; pH 7.2±7.4; to which 15000 IU heparin/l were added) at room temperature, followed by an ice-cold periodate±lysine± paraformaldehyde solution [16] . The right atrium was opened to enable venous out¯ow.
The superior cervical ganglia (SCG) and the trigeminal ganglia (TG) of both sides were removed, post-®xed for 1 h and stored overnight at 48C in phosphate-buffered 30% sucrose. The tissue was sectioned serially at 40 ìm on a freezing microtome in a longitudinal plane and collected in PBS.
For immunohistochemistry, sections were incubated free-¯oating in a polyclonal rabbit-raised antiserum directed against neuronal nitric oxide synthase from rat cerebellum (nNOS, 1:1000 in PBS; Laboserv, Giessen, Germany), to which 1% normal swine serum and 0.1% Triton-X 100 were added. This antibody is well characterized [17] and has been used in our laboratory in a variety of studies [8, 9, 18] . After three rinses in PBS, sections were incubated in biotinylated anti-rabbit-IgG (1:100 in PBS; Amersham, Hannover, Germany). The reaction was visualized using Cy3 conjugated to streptavidin (1:100 in PBS, Amersham) as detection system. Sections were mounted onto gelatin-coated slides, brie¯y dehydrated, coverslipped with Merckoglas (Merck, Darmstadt, Germany) and analyzed using a Leitz Orthoplan microscope with a Ploemopak epi¯uorescence unit through ®lter sets D (FluoroGold) and N2 (Cy3).
From each section, labeled cells were quanti®ed. Single-and double-labeled neurons were counted separately. Photomicrographs were taken on Ilford HP 5 ®lms. Speci®city studies, carried out by omitting primary or secondary antisera or by absorbing with the immunogen, showed the absence of the¯uorescent signal.
Results
Upon application of FG into the left cochlea and retrograde transport, the tracer was observed in neuronal cell bodies of the trigeminal (TG) and the superior cervical ganglion (SCG) in both, rat and guinea pig. The numbers of cells are given in Table  1 . Location, staining intensity and morphology of FG-labeled and nNOS-stained structures were similar in rat and guinea pig.
In the TG, cell bodies labeled by FG were found ipsilateral to the injection site (Table 1 ; Fig. 1A,C) . Labeled perikarya were not seen in the contralateral TG. The majority of these cell bodies was located in the anteromedial portion of the ganglion. The number of FG-labeled perikarya was slightly higher in rats than in guinea pigs (Table 1) . In both species, approximately 14% of the FG-labeled TG cells also exhibited nNOS immunoreactivity (Table 1 ; Fig. 1B,D) . These double-labeled TG cells were found within cell clusters of up to 70 nNOSimmunoreactive cells. Most of the TG neurons were neither FG-labeled nor nNOS-ir.
In the SCG of rat and guinea pig, FG-labeled cell bodies were observed ipsilateral to the injection site (Table 1 ; Fig. 2A,B) . The majority of these neurons (. 70%) was seen in the cranial half of the ganglion. FG labeling did not occur in the contralateral SCG. Neuronal NOS-ir perikarya were not seen in the SCG but spot-like nNOS immunoreactivies in the close vicinity to FG-labeled ganglion cells (Fig. 2B,D) were observed. These results were similar in both rat and guinea pig.
Discussion
The present results obtained from rat and guinea pig reveal that some trigeminal neurons innervating the ipsilateral cochlea are nNOS-ir. Our data thus support recent results [11] demonstrating a trigeminal innervation of the cochlea and extend these ®ndings by showing that this innervation may provide NO to the cochlea. Neuronal NOS was previously detected by histochemical and immunohistochemical methods in the rat TG [12] . Soluble guanylyl cyclase which is activated by NO has also been found in TG cells of guinea pigs, indicating that NO plays a role in TG neuronal transmission [13] . In the cochlea, NO in¯uences the regulation of blood¯ow [1, 19] . Puta- tive sources of NO responsible for these effects are the cochlear glomeruli and the stria vascularis in which the epithelial isoform of NOS (eNOS) has been demonstrated [5, 20] . We now present the ®rst evidence to show that a considerable number of TG neurons which project to the cochlea contain nNOS-ir. Since nNOS has been demonstrated in spiral ganglion cells [5±8] and in neurons of the auditory brain stem providing the olivocochlear bundle [8, 9] , trigeminal ganglion cells which have been identi®ed in the present study may be an additional source of cochlear NO.
A previous study [21] described labeled cell bodies in the sympathetic SCG ipsilateral to the injection site upon application of a retrograde tracer into the inner ear of rats. The present data con®rm and extend these ®ndings by demonstrating that the density of cochlea-projecting SCG cells is almost identical in rats and guinea pigs and that in both species none of these neurons are nNOS-ir. The lack of nNOS-ir in cell bodies of the SCG in our results con®rms previous studies utilizing histochemical and immunohistochemical methods [12, 22, 23] . It is therefore unlikely that the effects on the ipsilateral cochlear blood¯ow evoked by electrical SCG stimulation [24] are due to NO release from sympathetic ®bers.
Interestingly, we found terminal-like nNOS-ir structures in close vicinity to retrogradely labeled SCG cells suggesting that they synapse with SCG cells that send their axon into the cochlea. It is likely that these nerve ®bers belong to preganglionic sympathetic neurons which have previously been described to be nNOS-ir in rats [25] .
Conclusion
Combined retrograde tracing and immunohistochemical experiments in rats and guinea pigs indicate that nNOS-immunoreactive neurons of the trigeminal ganglion project to the ipsilateral cochlea. This trigemino-cochlear projection may serve as an additional source of cochlear NO. In contrast, neurons of the superior cervical ganglion innervating the cochlea do not exhibit nNOS immunoreactivity.
